Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Stevanato, Gerresheimer Sign Agreement for Syringe Closure System | Contract Pharma
Breaking News

Stevanato, Gerresheimer Sign Agreement for Syringe Closure System

Gerresheimer adopts SG ITC for Gx RTF syringes

Stevanato Group’s SG ITC (Integrated Tip Cap) twist-off closure, is a user-friendly system solution for Luer Lock syringes, which will now be included in Gerresheimer program.

The integrated seal cap consists of two components: an elastomeric component, which is available in different formulations and a rigid, translucent polymer cap. Compared to traditional Luer Cone systems, this solution offers a syringe closure with increased stability, thus protecting the drug product, according to the company. The seal cap is securely screwed onto the Luer Lock syringe, so that accidental removal of the cap is prevented. The familiar twist-off function offers medical specialists improved user-friendliness without impairing the integrity of the pre-fillable syringes.

“We are delighted that Gerresheimer is adopting our leading technology. This closure system for syringes adds up to the EZ-fill® platform for vials Gerresheimer already joined a few years ago, broadening the standardized solutions available in the market. Pharma customers can benefit from increased flexibility, consistent quality and safety, and reduced time-to-market,” said Mauro Stocchi, Chief Business Officer at Stevanato Group.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters